Fluzone®

The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection

Immunogenicity and Safety of Different Doses of Fluzone® Influenza

Influenza Vaccine in Pregnant Women

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Study to Assess the Immunogenicity and Safety of an Investigational Influenza Vaccine in Children

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals

Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)

Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers (SLVP032)

The Human Mucosal Immune Responses to Influenza Virus (SLVP026)

Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)

Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)

Young Adult Influenza Vaccine Immunogenicity Substudy